FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change

Variability in 3-month changes in FVC was examined in 954 patients with IPF (n=3966 observations) from phase 3 trials; concurrent 3-month decline in the FVC and 6MWD (n=1321 observations) predicted further decline in FVC over the subsequent 3 months http://bit.ly/2GfBKW3

Detalles Bibliográficos
Autores principales: Nathan, Steven D., Yang, Ming, Morgenthien, Elizabeth A., Stauffer, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236864/
https://www.ncbi.nlm.nih.gov/pubmed/32029447
http://dx.doi.org/10.1183/13993003.02151-2019
_version_ 1783536223536545792
author Nathan, Steven D.
Yang, Ming
Morgenthien, Elizabeth A.
Stauffer, John L.
author_facet Nathan, Steven D.
Yang, Ming
Morgenthien, Elizabeth A.
Stauffer, John L.
author_sort Nathan, Steven D.
collection PubMed
description Variability in 3-month changes in FVC was examined in 954 patients with IPF (n=3966 observations) from phase 3 trials; concurrent 3-month decline in the FVC and 6MWD (n=1321 observations) predicted further decline in FVC over the subsequent 3 months http://bit.ly/2GfBKW3
format Online
Article
Text
id pubmed-7236864
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-72368642020-06-03 FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Nathan, Steven D. Yang, Ming Morgenthien, Elizabeth A. Stauffer, John L. Eur Respir J Agora Variability in 3-month changes in FVC was examined in 954 patients with IPF (n=3966 observations) from phase 3 trials; concurrent 3-month decline in the FVC and 6MWD (n=1321 observations) predicted further decline in FVC over the subsequent 3 months http://bit.ly/2GfBKW3 European Respiratory Society 2020-05-14 /pmc/articles/PMC7236864/ /pubmed/32029447 http://dx.doi.org/10.1183/13993003.02151-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Nathan, Steven D.
Yang, Ming
Morgenthien, Elizabeth A.
Stauffer, John L.
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
title FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
title_full FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
title_fullStr FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
title_full_unstemmed FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
title_short FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
title_sort fvc variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236864/
https://www.ncbi.nlm.nih.gov/pubmed/32029447
http://dx.doi.org/10.1183/13993003.02151-2019
work_keys_str_mv AT nathanstevend fvcvariabilityinpatientswithidiopathicpulmonaryfibrosisandroleof6minwalktesttopredictfurtherchange
AT yangming fvcvariabilityinpatientswithidiopathicpulmonaryfibrosisandroleof6minwalktesttopredictfurtherchange
AT morgenthienelizabetha fvcvariabilityinpatientswithidiopathicpulmonaryfibrosisandroleof6minwalktesttopredictfurtherchange
AT staufferjohnl fvcvariabilityinpatientswithidiopathicpulmonaryfibrosisandroleof6minwalktesttopredictfurtherchange

Ejemplares similares